✦ LIBER ✦
A phase II trial of pegylated interferon α-2b therapy for polycythemia vera and essential thrombocythemia : Feasibility, clinical and biologic effects, and impact on quality of life
✍ Scribed by Jan Samuelsson; Hans Hasselbalch; Oystein Bruserud; Snezana Temerinac; Yvonne Brandberg; Mats Merup; Olle Linder; Magnus Bjorkholm; Heike L. Pahl; Gunnar Birgegard; Nordic Study Group for Myeloproliferative Disorders
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 155 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.